NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188 | -19.7% | 146 | +12.3% | 0.00% | – |
| Q2 2023 | $234 | +26.5% | 130 | +4.0% | 0.00% | – |
| Q1 2023 | $185 | +6.9% | 125 | +1.6% | 0.00% | – |
| Q4 2022 | $173 | – | 123 | +2.5% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 120 | +0.8% | 0.00% | – |
| Q2 2022 | $1,000 | – | 119 | +376.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 25 | -98.4% | 0.00% | – |
| Q3 2021 | $11,000 | -92.0% | 1,595 | -90.8% | 0.00% | – |
| Q2 2021 | $138,000 | -30.7% | 17,308 | -13.3% | 0.00% | – |
| Q1 2021 | $199,000 | -61.6% | 19,959 | -58.0% | 0.00% | – |
| Q4 2020 | $518,000 | -0.6% | 47,555 | -19.7% | 0.00% | – |
| Q3 2020 | $521,000 | -56.8% | 59,197 | +5.2% | 0.00% | – |
| Q2 2020 | $1,206,000 | +143.6% | 56,252 | +321.4% | 0.00% | – |
| Q1 2020 | $495,000 | -13.5% | 13,350 | +31.4% | 0.00% | – |
| Q4 2019 | $572,000 | +1171.1% | 10,157 | +597.1% | 0.00% | – |
| Q3 2019 | $45,000 | – | 1,457 | +6838.1% | 0.00% | – |
| Q2 2019 | $0 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |